At the Janssen Pharmaceutical Companies of Johnson & Johnson, we are working to create a world without disease. Transforming lives by finding new and better ways to prevent, intercept, treat and cure disease inspires us. We bring together the best minds and pursue the most promising science. We are Janssen. We collaborate with the world for the health of everyone in it. Learn more at www.janssen.com and follow us @JanssenGlobal. Janssen Research & Development, LLC is part of the Janssen Pharmaceutical Companies.
Janssen GPH (Global Public Health) utilizes the resources, capabilities, pharmaceuticals, technologies, and programs of Janssen R&D to bring new innovations to impact the health and well-being of underserved communities globally. The GPH portfolio includes SIRTURO (bedaquiline), the first new drug for the treatment of tuberculosis in 40 years, as well as projects in HIV treatment, Dengue prevention and treatment, COVID-19 and a Long-Acting formulation platform for diverse infectious diseases.
The Clinical Leader (CL) will lead the development and execution of clinical plan for a Ph1/2/3 program in Mycobacterial Diseases. Specifically, the CL is responsible for the clinical development plans, protocol development, quality and timely execution of clinical studies, preparation and ownership of clinical study reports, leading the health authority meetings for clinical/medical issues and for the preparation and approval of crucial documents for regulatory filings. The CL will lead the cross-functional clinical team and will lead direct reports who are project physicians or project scientists. The CL is a critical member in the compound development team (CDT) and will interact with individuals from strategy leader (CDT Leader), clinical operation, project management, regulatory affairs, commercial, legal, quality assurance & compliance, CMC, biostatistics, global medical safety, clinical pharmacology and other scientific and business related fields. The CL is also expected to assist in the leadership of the evaluation of scientific opportunities in the therapeutic area, as well as supporting external research collaborations.
Johnson & Johnson Family of Companies are equal opportunity employers, and all qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, genetic information, national origin, protected veteran status, disability status, or any other characteristic protected by law.
We will ensure that individuals with disabilities are provided reasonable accommodation to participate in the job application or interview process, to perform essential job functions, and to receive other benefits and privileges of employment. Please contact us to request accommodation!